Exploration of Antioxidant, Anti-inflammatory and Anticancer Potential of Substituted 4-Thiazolidinone Derivatives: Synthesis, Biological Evaluation and Docking Studies

References

• A. M. Isloor, D. Sunil, P. Shetty, S. Malladi, K. Pai, and N. Maliyakkl, “Synthesis, Characterization, Anticancer, and Antioxidant Activity of Some New Thiazolidin-4-Ones in MCF-7 Cells,” Medicinal Chemistry Research 22, no. 2 (2013): 758–67.
   Web of Science ®Google Scholar
• K. Bedard, and K.-H. Krause, “The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology,” Physiological Reviews 87, no. 1 (2007): 245–313.
   PubMed Web of Science ®Google Scholar
• A. Gonzalez-Periz, and J. Claria, “New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways,” Current Topics in Medicinal Chemistry 7, no. 3 (2007): 297–309.
   PubMed Web of Science ®Google Scholar
• G. Vendemiale, I. Grattagliano, and E. Altomare, “An Update on the Role of Free Radicals and Antioxidant Defense in Human Disease,” International Journal of Clinical & Laboratory Research 29, no. 2 (1999): 49–55.
   PubMedGoogle Scholar
• Ş. G. Küçükgüzel, İ. Coşkun, S. Aydın, G. Aktay, Ş. Gürsoy, Ö. Çevik, Ö. B. Özakpınar, D. Özsavcı, A. Şener, N. Kaushik-Basu, et al, “Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents,” Molecules (Basel, Switzerland) 18, no. 3 (2013): 3595–614.
   PubMed Web of Science ®Google Scholar
• A.-W. Wu, J. Gu, J.-F. Ji, Z.-F. Li, and G.-W. Xu, “Role of COX-2 in Carcinogenesis of Colorectal Cancer and Its Relationship with Tumor Biological Characteristics and Patients’ Prognosis,” World Journal of Gastroenterology 9, no. 9 (2003): 1990–4.
   PubMed Web of Science ®Google Scholar
• B. Liu, L. Qu, and S. Yan, “Cyclooxygenase-2 Promotes Tumor Growth and Suppresses Tumor Immunity,” Cancer Cell International 15, no. 1 (2015): 106.
   PubMedGoogle Scholar
• S. K. Suthar, V. Jaiswal, S. Lohan, S. Bansal, A. Chaudhary, A. Tiwari, A. T. Alex, and A. Joesph, “Novel Quinolone Substituted Thiazolidin-4-Ones as Anti-Inflammatory, Anticancer Agents: Design, Synthesis and Biological Screening,” European Journal of Medicinal Chemistry 63 (2013): 589–602.
   PubMed Web of Science ®Google Scholar
• World Health Organization Cancer. http://www.who.int/cancer/en/.
   Google Scholar
• N. Kerru, P. Singh, N. Koorbanally, R. Raj, and V. Kumar, “Recent Advances (2015–2016) in Anticancer Hybrids,” European Journal of Medicinal Chemistry 142 (2017): 179–212.
   PubMed Web of Science ®Google Scholar
• World Health Organization cancer. http://www.who.int/mediacentre/factsheets/fs297/en/.
   Google Scholar
• H. Armstrong, M. Bording-Jorgensen, S. Dijk, and E. Wine, “The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What we Can Do to Prevent It,” Cancers (Basel) 10, no. 3 (2018): 83.
   PubMed Web of Science ®Google Scholar
• J. Parsonnet, “Bacterial Infection as a Cause of Cancer,” Environmental Health Perspectives 103, no. suppl8 (1995): 263–8.
   PubMedGoogle Scholar
• D. Kaminskyy, A. Kryshchyshyn, and R. Lesyk, “5-Ene-4-Thiazolidinones–an Efficient Tool in Medicinal Chemistry,” European Journal of Medicinal Chemistry 140 (2017): 542–94.
   PubMed Web of Science ®Google Scholar
• B. Goel, T. Ram, R. Tyagi, E. Bansal, A. Kumar, D. Mukherjee, and J. N. Sinha, “2-Substituted-3-(4-Bromo-2-Carboxyphenyl)-5-Methyl-4-Thiazolidinones as Potential Anti-Inflammatory Agents,” European Journal of Medicinal Chemistry 34, no. 3 (1999): 265–9.
   Web of Science ®Google Scholar
• R. Ottanà, R. Maccari, M. L. Barreca, G. Bruno, A. Rotondo, A. Rossi, G. Chiricosta, R. Di Paola, L. Sautebin, S. Cuzzocrea, et al, “5-Arylidene-2-Imino-4-Thiazolidinones: Design and Synthesis of Novel Anti-Inflammatory Agents,” Bioorganic & Medicinal Chemistry 13, no. 13 (2005): 4243–52.
   PubMed Web of Science ®Google Scholar
• K. Omar, A. Geronikaki, P. Zoumpoulakis, C. Camoutsis, M. Soković, A. Ćirić, and J. Glamočlija, “Novel 4-Thiazolidinone Derivatives as Potential Antifungal and Antibacterial Drugs,” Bioorganic & Medicinal Chemistry 18, no. 1 (2010): 426–32.
   PubMed Web of Science ®Google Scholar
• P. Vicini, A. Geronikaki, K. Anastasia, M. Incerti, and F. Zani, “Synthesis and Antimicrobial Activity of Novel 2-Thiazolylimino-5-Arylidene-4-Thiazolidinones,” Bioorganic & Medicinal Chemistry 14, no. 11 (2006): 3859–64.
   PubMed Web of Science ®Google Scholar
• A. Deep, S. Jain, P. C. Sharma, P. Phogat, and M. Malhotra, “Synthesis of 2-(Aryl)-5-(Arylidene)-4-Thiazolidinone Derivatives with Potential Analgesic and Anti-Inflammatory Activity,” Medicinal Chemistry Research 21, no. 8 (2012): 1652–9.
   Web of Science ®Google Scholar
• D. Havrylyuk, L. Mosula, B. Zimenkovsky, O. Vasylenko, A. Gzella, and R. Lesyk, “Synthesis and Anticancer Activity Evaluation of 4-Thiazolidinones Containing Benzothiazole Moiety,” European Journal of Medicinal Chemistry 45, no. 11 (2010): 5012–21.
   PubMed Web of Science ®Google Scholar
• S. Wang, Y. Zhao, W. Zhu, Y. Liu, K. Guo, and P. Gong, “Synthesis and Anticancer Activity of Indolin‐2‐One Derivatives Bearing the 4‐Thiazolidinone Moiety,” Archiv der Pharmazie 345, no. 1 (2012): 73–80.
   PubMed Web of Science ®Google Scholar
• N. Abdul‐Kader Saleh, H. El‐Abd Saltani, F. Abbas Al‐Issa, A. Abul‐Kasem Errabie, and A. S. Gomaa Melad, “Evaluation of Antifungal and Antioxidant Activity of Newly Synthesized 4‐Thiazolidinones,” Journal of the Chinese Chemical Society 60, no. 11 (2013): 1353–8.
   Web of Science ®Google Scholar
• J. Panetta, J. Shadle, M. Phillips, D. Benslay, and P. Ho, “4‐Thiazolidinones, Potent Antioxidants, as Antiinflammatory Agents,” Annals of the New York Academy of Sciences 696, no. 1 (1993): 415–6.
   PubMedGoogle Scholar
• S. V. Bhandari, K. G. Bothara, A. A. Patil, T. S. Chitre, A. P. Sarkate, S. T. Gore, S. C. Dangre, and C. V. Khachane, “Design, Synthesis and Pharmacological Screening of Novel Antihypertensive Agents Using Hybrid Approach,” Bioorganic & Medicinal Chemistry 17, no. 1 (2009): 390–400.
   PubMed Web of Science ®Google Scholar
• G. Çapan, N. Ulusoy, N. Ergenç, and M. Kiraz, “New 6-Phenylimidazo [2, 1-b] Thiazole Derivatives: Synthesis and Antifungal Activity,” Monatshefte für Chemie/Chemical Monthly 130, no. 11 (1999): 1399–407.
   Web of Science ®Google Scholar
• G. H. Marques, A. Kunzler, V. D. O. Bareño, B. B. Drawanz, H. G. Mastelloto, F. R. M. Leite, G. G. Nascimento, P. S. Nascente, G. M. Siqueira, and W. Cunico, “Antifungal Activity of 3-(Heteroaryl-2-Ylmethyl) Thiazolidinone Derivatives,” Medicinal Chemistry (Shariqah (United Arab Emirates)) 10, no. 4 (2014): 355–60.
   PubMed Web of Science ®Google Scholar
• C. Kavitha, S. N. Swamy, K. Mantelingu, S. Doreswamy, M. Sridhar, J. S. Prasad, and K. S. Rangappa, “Synthesis of New Bioactive Venlafaxine Analogs: Novel Thiazolidin-4-Ones as Antimicrobials,” Bioorganic & Medicinal Chemistry 14, no. 7 (2006): 2290–9.
   PubMed Web of Science ®Google Scholar
• H. Varshney, A. Ahmad, N. N. Farshori, A. Ahmad, A. U. Khan, and A. Rauf, “Synthesis and Evaluation of in Vitro Antimicrobial Activity of Novel 2, 3-Disubstituted-4-Thiazolidinones from Fatty Acid Hydrazides,” Medicinal Chemistry Research 22, no. 7 (2013): 3204–12.
   Web of Science ®Google Scholar
• M. Vigorita, R. Ottana, F. Monforte, R. Maccari, A. Trovato, M. Monforte, and M. Taviano, “Synthesis and Antiinflammatory, Analgesic Activity of 3, 3′-(1, 2-Ethanediyl)-Bis [2-Aryl-4-Thiazolidinone] Chiral Compounds. Part 10,” Bioorganic & Medicinal Chemistry Letters 11, no. 21 (2001): 2791–4.
   PubMed Web of Science ®Google Scholar
• R. Ottanà, R. Maccari, R. Ciurleo, M. G. Vigorita, A. M. Panico, V. Cardile, F. Garufi, and S. Ronsisvalle, “Synthesis and in Vitro Evaluation of 5-Arylidene-3-Hydroxyalkyl-2-Phenylimino-4-Thiazolidinones with Antidegenerative Activity on Human Chondrocyte Cultures,” Bioorganic & Medicinal Chemistry 15, no. 24 (2007): 7618–25.
   PubMed Web of Science ®Google Scholar
• S. K. Sharabiyani, N. Foroughifar, and A. Khajeh-Amiri, “Using of Some Novel Derivatives of Thiourea for Synthesis of Pharmaceutical Compounds of 5-Arylidine-2-Imino-4-Thiazolidinones and Their Medicinal Properties Study as Anti-Inflammatory Agents,” International Journal of Advanced Engineering Research and Science (IJAERS) 4, no. 10 (2017): 237281.
   Google Scholar
• N. Singh, A. C. Tripathi, A. Tewari, R. Kumar, and S. K. Saraf, “Ulcerogenicity Devoid Novel Non-Steroidal Anti-Inflammatory Agents (NSAIDS): Syntheses, Computational Studies, and Activity of 5-Aryliden-2-Imino-4-Thiazolidinones,” Medicinal Chemistry Research 24, no. 5 (2015): 1927–41.
   Web of Science ®Google Scholar
• A. K. Chakraborti, S. K. Garg, R. Kumar, H. F. Motiwala, and P. S. Jadhavar, “Progress in COX-2 Inhibitors: A Journey so Far,” Current Medicinal Chemistry 17, no. 15 (2010): 1563–93.
   PubMed Web of Science ®Google Scholar
• A. A. Geronikaki, A. A. Lagunin, D. I. Hadjipavlou-Litina, P. T. Eleftheriou, D. A. Filimonov, V. V. Poroikov, I. Alam, and A. K. Saxena, “Computer-Aided Discovery of Anti-Inflammatory Thiazolidinones with Dual Cyclooxygenase/Lipoxygenase Inhibition,” Journal of Medicinal Chemistry 51, no. 6 (2008): 1601–9.
   PubMed Web of Science ®Google Scholar
• P. Chawla, S. Kalra, R. Kumar, R. Singh, and S. K. Saraf, “Novel 2-(Substituted Phenyl Imino)-5-Benzylidene-4-Thiazolidinones as Possible Non-Ulcerogenic Tri-Action Drug Candidates: Synthesis, Characterization, Biological Evaluation and Docking Studies,” Medicinal Chemistry Research 28, no. 3 (2019): 340–59.
   Web of Science ®Google Scholar
• P. Chawla, R. Singh, and S. K. Saraf, “Effect of Chloro and Fluoro Groups on the Antimicrobial Activity of 2, 5-Disubstituted 4-Thiazolidinones: A Comparative Study,” Medicinal Chemistry Research 21, no. 10 (2012): 3263–71.
   Web of Science ®Google Scholar
• P. Chawla, R. Singh, and S. K. Saraf, “Syntheses and Evaluation of 2, 5-Disubstituted 4-Thiazolidinone Analogues as Antimicrobial Agents,” Medicinal Chemistry Research 21, no. 8 (2012): 2064–71.
   Web of Science ®Google Scholar
• J. Xie, and K. Schaich, “Re-Evaluation of the 2, 2-Diphenyl-1-Picrylhydrazyl Free Radical (DPPH) Assay for Antioxidant Activity,” Journal of Agricultural and Food Chemistry 62, no. 19 (2014): 4251–60.
   PubMed Web of Science ®Google Scholar
• C. A. Winter, E. A. Risley, and G. W. Nuss, “Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs,” Proceedings of the Society for Experimental Biology and Medicine 111, no. 3 (1962): 544–7.
   PubMed Web of Science ®Google Scholar
• J. Zhou, G. Cheng, H. Pang, Q. Liu, and Y. Liu, “The Effect of 131I-Induced Hypothyroidism on the Levels of Nitric Oxide (NO), Interleukin 6 (IL-6), Tumor Necrosis Factor Alpha (TNF-α), Total Nitric Oxide Synthase (NOS) Activity, and Expression of NOS Isoforms in Rats,” Bosnian Journal of Basic Medical Sciences 18, no. 4 (2018): 305–12.
   PubMed Web of Science ®Google Scholar
• G. C. Franchi, C. S. Moraes, V. C. Toreti, A. Daugsch, A. E. Nowill, and Y. K. Park, “Comparison of Effects of the Ethanolic Extracts of Brazilian Propolis on Human Leukemic Cells as Assessed with the MTT Assay,” Evidence-Based Complementary and Alternative Medicine: eCAM 2012 (2012): 918956.
   PubMed Web of Science ®Google Scholar
• M. Djukic, M. Fesatidou, I. Xenikakis, A. Geronikaki, V. T. Angelova, V. Savic, M. Pasic, B. Krilovic, D. Djukic, B. Gobeljic, et al, “In Vitro Antioxidant Activity of Thiazolidinone Derivatives of 1, 3-Thiazole and 1, 3, 4-Thiadiazole,” Chemico-Biological Interactions 286 (2018): 119–31.
   PubMed Web of Science ®Google Scholar
• P.-C. Huang, K.-L. Tsai, Y.-W. Chen, H.-T. Lin, and C.-H. Hung, “Exercise Combined with Ultrasound Attenuates Neuropathic Pain in Rats Associated with Downregulation of IL-6 and TNF-α, but with Upregulation of IL-10,” Anesthesia and Analgesia 124, no. 6 (2017): 2038–44.
   PubMed Web of Science ®Google Scholar